Neurologic Functional Outcomes of Decompressive Hemicraniectomy Versus Conventional Treatment for Malignant Middle

Yu-Ping Li1, Meng-Zhuo Hou2, Guang-Yu Lu3

  • 1Department of Neurosurgery, The Clinical Medical College of Yangzhou University, Yangzhou, China; Neurosurgical Research, Department of Neurosurgery, Ludwig-Maximilians University of Munich, Munich, Germany.

World Neurosurgery
|December 28, 2016
PubMed

Insights

Decompressive hemicraniectomy (DHC) improves outcomes for malignant middle cerebral artery (MCA) infarction patients compared to conventional treatment (CT). While DHC reduces mortality and improves good functional outcomes, older patients face higher risks of severe disability.

Area of Science:

  • Neurosurgery
  • Neurology
  • Critical Care Medicine

Background:

  • Malignant middle cerebral artery (MCA) infarction poses a high risk of mortality and severe disability.
  • Conventional treatment (CT) has limited efficacy in managing the associated intracranial hypertension.
  • Decompressive hemicraniectomy (DHC) is a surgical option to reduce intracranial pressure.

Purpose of the Study:

  • To compare the efficacy of DHC versus CT in patients with malignant MCA infarction.
  • To evaluate the impact of patient age and surgical timing on neurological function and mortality.
  • To analyze functional outcomes and survival rates in different patient subgroups.

Main Methods:

  • A systematic meta-analysis of randomized controlled trials and observational studies was conducted.
  • Searched English and Chinese databases for studies published before August 2016.
  • Key outcomes included good functional outcome (GFO), mortality, National Institutes of Health Stroke Scale, and Barthel index scores.

Main Results:

  • DHC demonstrated statistically significant improvements in GFO and reduced mortality compared to CT.
  • No significant difference was found in survival with severe disability between DHC and CT groups.
  • Subgroup analysis revealed lower GFO and higher rates of severe disability in DHC patients over 60 years old.

Conclusions:

  • DHC significantly improves GFO and reduces mortality in malignant MCA infarction patients of all ages compared to CT.
  • DHC is associated with a higher incidence of moderately severe disability.
  • Elderly patients (>60 years) with malignant MCA infarction have a poorer prognosis, with increased risk of severe disability and reduced GFO even with DHC.
Abstract

Related Concept Videos